Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

484 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply.
Trauner M, Chung C, Myers RP, Kowdley KV. Trauner M, et al. Among authors: kowdley kv. Hepatology. 2020 Oct;72(4):1498-1499. doi: 10.1002/hep.31268. Hepatology. 2020. PMID: 32279334 No abstract available.
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F. Lindor KD, et al. Among authors: kowdley kv. Hepatology. 2009 Sep;50(3):808-14. doi: 10.1002/hep.23082. Hepatology. 2009. PMID: 19585548 Free PMC article. Clinical Trial.
The predictors of the presence of varices in patients with primary sclerosing cholangitis.
Treeprasertsuk S, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Schmoll J, Hoskin T, Thapa P, Enders F, Lindor KD. Treeprasertsuk S, et al. Among authors: kowdley kv. Hepatology. 2010 Apr;51(4):1302-10. doi: 10.1002/hep.23432. Hepatology. 2010. PMID: 20044810 Free PMC article. Clinical Trial.
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.
Hirschfield GM, Mason A, Luketic V, Lindor K, Gordon SC, Mayo M, Kowdley KV, Vincent C, Bodhenheimer HC Jr, Parés A, Trauner M, Marschall HU, Adorini L, Sciacca C, Beecher-Jones T, Castelloe E, Böhm O, Shapiro D. Hirschfield GM, et al. Among authors: kowdley kv. Gastroenterology. 2015 Apr;148(4):751-61.e8. doi: 10.1053/j.gastro.2014.12.005. Epub 2014 Dec 11. Gastroenterology. 2015. PMID: 25500425 Free article. Clinical Trial.
Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials.
Alqahtani SA, Afdhal N, Zeuzem S, Gordon SC, Mangia A, Kwo P, Fried M, Yang JC, Ding X, Pang PS, McHutchison JG, Pound D, Reddy KR, Marcellin P, Kowdley KV, Sulkowski M. Alqahtani SA, et al. Among authors: kowdley kv. Hepatology. 2015 Jul;62(1):25-30. doi: 10.1002/hep.27890. Epub 2015 Jun 1. Hepatology. 2015. PMID: 25963890 Clinical Trial.
Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.
Wilder JM, Jeffers LJ, Ravendhran N, Shiffman ML, Poulos J, Sulkowski MS, Gitlin N, Workowski K, Zhu Y, Yang JC, Pang PS, McHutchison JG, Muir AJ, Howell C, Kowdley K, Afdhal N, Reddy KR. Wilder JM, et al. Hepatology. 2016 Feb;63(2):437-44. doi: 10.1002/hep.28334. Epub 2015 Dec 18. Hepatology. 2016. PMID: 26547499 Free PMC article. Clinical Trial.
484 results